Tuesday, January 3, 2017

FDA nails a third Wockhardt plant with a warning letter

January 3, 2017 | By Eric Palmer
The FDA sidelined U.S. biotech Cempra’s new generation antibiotic with a complete response letter last week over safety concerns, but also because of issues it has with the Wockhardt plant making the API for it. 
ß
Reed Smith
Ever since Buckman Co. v. Plaintiffs' Legal Committee, 531 U.S. 341 (2001), held that state-law claims alleging fraud on the FDA are preempted, plaintiffs have been attempting to find some other way...
Today, the U.S. Food and Drug Administration announced that it has completed the implementation of Guidance for Industry #213, a process begun in 2013 to transition antimicrobial drugs with importance in human medicine (medically important antimicrobials) that are used in the feed or drinking water of food-producing animals to veterinary oversight and eliminate the use of these products in animals for production (e.g., growth promotion) purposes.
December 22, 2016Rock Solid Nutrition, LLCKansas City District OfficeCGMP/Dietary Supplement/Adulterated/MisbrandedNot Issued *
December 23, 2016Wockhardt, Ltd.Center for Drug Evaluation and ResearchCGMP/APIs/AdulteratedNot Issued *

Twelve Indicted in More than $100 Million Health Care Fraud involving prescribing compounded drugs

Twelve Indicted in More than $100 Million Health Care Fraud

Contemporary Clinic-2 hours ago
According to federal prosecutors, the scheme involved prescribing compounded drugs such as pain, scar, and migraine creams to military families covered by ...